Tech Company Financing Transactions
Pathos AI Funding Round
Pathos AI closed a $365 million Series D venture capital round on 5/15/2025. Investors included BuildersVC, New Enterprise Associates and Revolution Ventures.
Transaction Overview
Company Name
Announced On
5/15/2025
Transaction Type
Venture Equity
Amount
$365,000,000
Round
Series D
Proceeds Purpose
The new financing will support advancing the company's clinical-stage pipeline and further building out its platform.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
600 West Chicago Avenue 150
Chicago, IL 60654
USA
Chicago, IL 60654
USA
Phone
Undisclosed
Website
Email Address
Overview
Pathos is a clinical-stage biotechnology company focused on re-engineering drug development, leveraging the power of advanced AI technologies to bring precision medicines to market through partnerships with biopharmaceutical companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Iker Huerga
Browse more venture capital transactions:
Prev: 5/15/2025: Doji venture capital transaction
Next: 5/15/2025: TensorWave venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs